Mairs & Power Inc Danaher Corp Transaction History

Mairs & Power Inc

$10.5 Billion
Q3 2024

A detailed history of Mairs & Power Inc transactions in Danaher Corp stock. As of the latest transaction made, Mairs & Power Inc holds 753 shares of DHR stock, worth $180,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares

753

Previous 884 14.82%

Holding current value

$180,042

Previous $220,000 5.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$239.25 - $280.76 $31,341 - $36,779	-131 Reduced 14.82%	753 $209,000
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $2,826 - $3,215	-12 Reduced 1.34%	884 $220,000
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $74,111 - $84,542	-330 Reduced 26.92%	896 $223,000
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $1,295 - $1,631	7 Added 0.57%	1,226 $283,000
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $36,593 - $41,697	-157 Reduced 11.41%	1,219 $302,000
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $1,124 - $1,280	5 Added 0.36%	1,376 $330,000
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $103,092 - $119,110	430 Added 45.7%	1,371 $345,000
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $16,899 - $19,760	70 Added 8.04%	941 $249,000
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $92,235 - $116,567	-389 Reduced 30.87%	871 $221,000
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $77,438 - $95,043	301 Added 31.39%	1,260 $370,000
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $11,099 - $12,502	38 Added 4.13%	959 $316,000
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $10,625 - $12,273	-50 Reduced 5.15%	921 $205,000
Q3 2020 Nov 16, 2020	BUY	$177.16 - $215.33 $172,022 - $209,085	971 New	971 $209,000

Others Institutions Holding DHR

# of Institutions

2,509

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account